<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>Icerocket blog search: tag:paclitaxel</title>
<link>http://blogs.icerocket.com/search?q=tag%3Apaclitaxel</link>
<description>Blogs Search from IceRocket.com</description>
<language>en-us</language>
<copyright>Copyright 2009, IceRocket.com</copyright>
<item>
 <title><![CDATA[A couple of more days]]></title>
 <description><![CDATA[I enjoyed a really nice weekend – ate lots of good food, including one of my favorites baby back ribs, spent time with my daughter, finished the solo campaign in Call of Duty: Modern Warfare 2 and am now working my way through Special Ops. My chemotherapy treatments will start this Thursday. This wi <b>...</b> ]]></description>
 <link><![CDATA[http://mytnbcjourney.com/?p=190]]></link>
 <pubDate>Tue, 17 Nov 2009 06:55:00 CST</pubDate>
 <guid isPermaLink="false"><![CDATA[e1ae6259c808aa642dd75adc9e500285]]></guid>
 <dc:creator>admin</dc:creator>
 <source url="http://mytnbcjourney.com">My TNBC Journey</source>
</item>
<item>
 <title><![CDATA[Approved]]></title>
 <description><![CDATA[Approval to participate in the clinical trial was received this afternoon: Randomized phase II 2×2 factorial trial of the addition of carboplatin and/or bevacizumab to neoadjuvant weekly paclitaxel followed by dose-dense AC in hormone receptor-poor/HER2-negative resectable breast cancer. All my bodi <b>...</b> ]]></description>
 <link><![CDATA[http://mytnbcjourney.com/?p=136]]></link>
 <pubDate>Mon, 9 Nov 2009 17:00:00 CST</pubDate>
 <guid isPermaLink="false"><![CDATA[96afff15cd2ec913e78cdc722cb38a1d]]></guid>
 <dc:creator>admin</dc:creator>
 <source url="http://mytnbcjourney.com">My TNBC Journey</source>
</item>
<item>
 <title><![CDATA[ΝΕΥΡΟΛΟΓΙΑ – ΟΓΚΟΙ : ΚΑΡΚΙΝΟΓΟΝΑ ΒΛΑΣΤΟΚΥΤΤΑΡΑ, ΣΑΛΙΝΟΜΥΚΙΝΗ]]></title>
 <description><![CDATA[ΜΕ ΤΗΝ ΑΝΑΚΑΛΥΨΗ ΤΗΣ ΣΑΛΙΝΟΜΥΚΙΝΗΣ ΕΠΙΤΕΥΧΘΗΚΕΕΝΑ ΚΑΙΝΟΥΡΙΟ ΒΗΜΑ ΣΤΗΝ ΘΕΡΑΠΕΙΑ ΤΩΝ ΚΑΡΚΙΝΩΝ. Μετά την ανακάλυψη των ιδιαιτεροτήτων των καρκινογόνων βλαστοκυττάρων το επόμενο βήμα ήτανε να βρεθεί μια θεραπευτική λύση για το οξύ πρόβλημα αυτό για τις διάφορες μορφές καρκίνου όπως είναι του στήθους και <b>...</b> ]]></description>
 <link><![CDATA[http://neurotalk.blogspot.com/2009/11/blog-post_3782.html]]></link>
 <pubDate>Mon, 9 Nov 2009 08:08:00 CST</pubDate>
 <guid isPermaLink="false"><![CDATA[6ad9a16b7b5ff90d492dc52641130a31]]></guid>
 <dc:creator> (Dr D. Kountouris)</dc:creator>
 <source url="http://neurotalk.blogspot.com/">NEURO-TALKS / ΝΕΥΡΟ-ΔΙΑΛΟΓΟΙ</source>
</item>
<item>
 <title><![CDATA[Decision Time]]></title>
 <description><![CDATA[In an earlier post I wrote about my opportunity to participate in the clinical trial: Randomized phase II 2×2 factorial trial of the addition of carboplatin and/or bevacizumab to neoadjuvant weekly paclitaxel followed by dose-dense AC in hormone receptor-poor/HER2-negative resectable breast cancer.  <b>...</b> ]]></description>
 <link><![CDATA[http://mytnbcjourney.com/?p=86]]></link>
 <pubDate>Sun, 8 Nov 2009 20:26:00 CST</pubDate>
 <guid isPermaLink="false"><![CDATA[7dfc1e0cefd47050a5ef3cca355fd8cf]]></guid>
 <dc:creator>admin</dc:creator>
 <source url="http://mytnbcjourney.com">My TNBC Journey</source>
</item>
<item>
 <title><![CDATA[What About the Rain Forest and Herbal Remedies?]]></title>
 <description><![CDATA[Are the rain forests safe?With all the attention in the news these days concerning the depletion of the Amazon rain forest, you might be concerned about the supply of herbal remedies from South America. What happens to all those amazing plants that are used everyday by millions of women to get menop <b>...</b> ]]></description>
 <link><![CDATA[http://natureherbalworld.com/382/what-about-the-rain-forest-and-herbal-remedies/]]></link>
 <pubDate>Sat, 24 Oct 2009 04:18:00 CDT</pubDate>
 <guid isPermaLink="false"><![CDATA[785cabd560729ad2cb53b4bb0b05f52a]]></guid>
 <source url="http://natureherbalworld.com">Nature Herbal World</source>
</item>
<item>
 <title><![CDATA[Prostate Cancer Treatment – What Kind of Drugs are Used to Treat Prostate Cancer]]></title>
 <description><![CDATA[Doctors will try different medications before referring you to a medical oncologist. If you are referred to one that would imply that your prostate cancer has reached an advanced stage. They would then be speaking about Chemotherapy. Chemotherapy will destroy the cancer cells by interfering with the <b>...</b> ]]></description>
 <link><![CDATA[http://www.pharmaceuticalclinicaltrials.com/prostate-cancer-treatment-what-kind-of-drugs-are-used-to-treat-prostate-cancer/]]></link>
 <pubDate>Wed, 21 Oct 2009 07:53:00 CDT</pubDate>
 <guid isPermaLink="false"><![CDATA[58353f0f39c9aafc0f94bf0417bd5709]]></guid>
 <dc:creator>Pharma Tech</dc:creator>
 <source url="http://www.pharmaceuticalclinicaltrials.com">Pharmaceutical Clinical Trials</source>
</item>
<item>
 <title><![CDATA[Pfizer halts enrollment in Phase III cancer study]]></title>
 <description><![CDATA[Alarmed by signs that patients in a late-stage lung cancer drug study were afflicted by a higher rate of adverse events than the volunteers in a placebo arm, Pfizer says it opted to halt enrollment until it can gain a better understanding of what is happening. The adverse events, which include death <b>...</b> ]]></description>
 <link><![CDATA[http://www.pharmafeed.com/pfizer-halts-enrollment-in-phase-iii-cancer-study]]></link>
 <pubDate>Tue, 13 Oct 2009 08:22:00 CDT</pubDate>
 <guid isPermaLink="false"><![CDATA[5df2576c6daa20b2f1de42251e26f82c]]></guid>
 <dc:creator>pharmafeed</dc:creator>
 <source url="http://www.pharmafeed.com">PharmaFeed</source>
</item>
<item>
 <title><![CDATA[YM BioSciences to Take Over Cytopia Gaining Base in Australia]]></title>
 <description><![CDATA[YM BioSciences has proposed to merge with Melbourne-based Cytopia to complement its cancer-focused pipeline. The stock-for-stock deal will also allow YM the opportunity to begin clinical trials in Australia with its oncology drug nimotuzumab, which is already approved in 21 countries. YM will also n <b>...</b> ]]></description>
 <link><![CDATA[http://www.pharmafeed.com/ym-biosciences-to-take-over-cytopia-gaining-base-in-australia]]></link>
 <pubDate>Wed, 7 Oct 2009 06:19:00 CDT</pubDate>
 <guid isPermaLink="false"><![CDATA[4c57377c7a0fc82070ce37200eb5fffe]]></guid>
 <dc:creator>pharmafeed</dc:creator>
 <source url="http://www.pharmafeed.com">PharmaFeed</source>
</item>
<item>
 <title><![CDATA[Modified Chemo Regime Increases Survival In Advanced Ovarian Cancer Patients But Adds Toxicity]]></title>
 <description><![CDATA[Women with advanced ovarian cancer lived longer and without their tumors growing after receiving a modified regimen of a standard chemotherapy drug combination, Japanese researchers reported last week. In a large phase III clinical trial, women who received carboplatin every 3 weeks and a reduced do <b>...</b> ]]></description>
 <link><![CDATA[http://healthinfoispower.wordpress.com/2009/09/24/modified-chemo-regime-increases-survival-in-advanced-ovarian-cancer-patients-but-adds-toxicity/]]></link>
 <pubDate>Thu, 24 Sep 2009 15:44:00 CDT</pubDate>
 <guid isPermaLink="false"><![CDATA[0b28f193e6f24cd95054f7748351578a]]></guid>
 <dc:creator>Paul Cacciatore</dc:creator>
 <source url="http://healthinfoispower.wordpress.com">Libby&#039;s H*O*P*E*</source>
</item>
<item>
 <title><![CDATA[There's no such thing as a free lunch - unless you're running a non-inferiority trial. Gefitinib for pulmonary adenocarcinoma]]></title>
 <description><![CDATA[A 20% difference in some outcome is either clinically relevant, or it is not. If A is worse than B by 19% and that's NOT clinically relevant and significant, then A being better than B by 19% must also NOT be clinically relevant and significant. But that is not how the authors of trials such as this <b>...</b> ]]></description>
 <link><![CDATA[http://medicalevidence.blogspot.com/2009/09/theres-no-such-thing-as-free-lunch.html]]></link>
 <pubDate>Sun, 6 Sep 2009 22:17:00 CDT</pubDate>
 <guid isPermaLink="false"><![CDATA[5a9d455350e152701a77c0baed84e649]]></guid>
 <dc:creator>Scott K. Aberegg, M.D., M.P.H., FCCP </dc:creator>
 <source url="http://medicalevidence.blogspot.com/">Medical Evidence Blog</source>
</item>
</channel>
</rss>


